(Q39557153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

A tetrazolato-bridged dinuclear platinum(II) complex exhibits markedly high in vivo antitumor activity against pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Yuh-Ling Lin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Masahiko Chikuma

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

15 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

987-990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

Platinum Compounds: a New Class of Potent Antitumour Agents

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

Structure and isomerization of an intrastrand cisplatin-cross-linked octamer DNA duplex by NMR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

A pyrazolato-bridged dinuclear platinum(II) complex induces only minor distortions upon DNA-binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA) in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

Ongoing and unsaid on oxaliplatin: the hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

Towards Antitumor Active trans-Platinum Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

Preclinical perspectives on the use of platinum compounds in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

New antitumor-active azole-bridged dinuclear platinum(II) complexes: synthesis, characterization, crystal structures, and cytotoxic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100141

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201100141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21500354%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference